BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30721151)

  • 1. Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.
    Stefan-Lifshitz M; Karakose E; Cui L; Ettela A; Yi Z; Zhang W; Tomer Y
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30721151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes.
    Rui J; Deng S; Perdigoto AL; Ponath G; Kursawe R; Lawlor N; Sumida T; Levine-Ritterman M; Stitzel ML; Pitt D; Lu J; Herold KC
    Nat Commun; 2021 Aug; 12(1):5074. PubMed ID: 34417463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
    Wang X; Feng Z; Li Q; Yi B; Xu Q
    Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes.
    Scherm MG; Serr I; Zahm AM; Schug J; Bellusci S; Manfredini R; Salb VK; Gerlach K; Weigmann B; Ziegler AG; Kaestner KH; Daniel C
    Nat Commun; 2019 Dec; 10(1):5697. PubMed ID: 31836704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation.
    Fu X; Jin L; Wang X; Luo A; Hu J; Zheng X; Tsark WM; Riggs AD; Ku HT; Huang W
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17892-7. PubMed ID: 24114270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D supplementation induces CatG-mediated CD4
    Lai X; Liu X; Cai X; Zou F
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E74-E84. PubMed ID: 34779254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxymethylation of microRNA-365-3p Regulates Nociceptive Behaviors via Kcnh2.
    Pan Z; Zhang M; Ma T; Xue ZY; Li GF; Hao LY; Zhu LJ; Li YQ; Ding HL; Cao JL
    J Neurosci; 2016 Mar; 36(9):2769-81. PubMed ID: 26937014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
    Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
    Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells.
    Ichiyama K; Chen T; Wang X; Yan X; Kim BS; Tanaka S; Ndiaye-Lobry D; Deng Y; Zou Y; Zheng P; Tian Q; Aifantis I; Wei L; Dong C
    Immunity; 2015 Apr; 42(4):613-26. PubMed ID: 25862091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
    Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
    J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction.
    Colli ML; Hill JLE; Marroquí L; Chaffey J; Dos Santos RS; Leete P; Coomans de Brachène A; Paula FMM; Op de Beeck A; Castela A; Marselli L; Krogvold L; Dahl-Jorgensen K; Marchetti P; Morgan NG; Richardson SJ; Eizirik DL
    EBioMedicine; 2018 Oct; 36():367-375. PubMed ID: 30269996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage to β cells in culture recapitulates features of senescent β cells that accumulate in type 1 diabetes.
    Brawerman G; Pipella J; Thompson PJ
    Mol Metab; 2022 Aug; 62():101524. PubMed ID: 35660116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.
    Takayama K; Misawa A; Suzuki T; Takagi K; Hayashizaki Y; Fujimura T; Homma Y; Takahashi S; Urano T; Inoue S
    Nat Commun; 2015 Sep; 6():8219. PubMed ID: 26404510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.
    Ko M; An J; Bandukwala HS; Chavez L; Aijö T; Pastor WA; Segal MF; Li H; Koh KP; Lähdesmäki H; Hogan PG; Aravind L; Rao A
    Nature; 2013 May; 497(7447):122-6. PubMed ID: 23563267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-eleven Translocation-2 Regulates DNA Hydroxymethylation Status and Psoriasiform Dermatitis Progression in Mice.
    Wang X; Liu X; Duan X; Zhu K; Zhang S; Gan L; Liu N; Jaypaul H; Makamure JT; Ming Z; Chen H
    Acta Derm Venereol; 2018 Jun; 98(6):585-593. PubMed ID: 29542811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.
    Eizirik DL; Sammeth M; Bouckenooghe T; Bottu G; Sisino G; Igoillo-Esteve M; Ortis F; Santin I; Colli ML; Barthson J; Bouwens L; Hughes L; Gregory L; Lunter G; Marselli L; Marchetti P; McCarthy MI; Cnop M
    PLoS Genet; 2012; 8(3):e1002552. PubMed ID: 22412385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
    Christen U; Kimmel R
    Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
    Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
    J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.